Lexeo Therapeutics Stock (NASDAQ: LXEO) stock price, news, charts, stock research, profile.
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR) and Genfit (NASDAQ:GNFT).
Lexeo Therapeutics has a consensus price target of $22.71.
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $5.07 last updated January 17, 2025 at 4:20 PM EST.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q4 earnings are confirmed for Friday, January 31, 2025.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.